Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash Flows from Operating Activities:
Net income	$ 111,511	$ 126,452	$ 118,352
Amounts to reconcile net income to net cash flows provided by operating activities:
Benefit for deferred income taxes	(13,847)	(5,877)	(89,530)
Depreciation and amortization	114,383	112,278	116,528
Amortization of deferred financing costs	5,505	5,959	5,500
Amortization of discount on convertible notes		8,735	13,817
Impairment and other charges	19,200		3,527
(Gain) loss on sales of long-lived assets	270	(25,274)	(82)
Loss on extinguishment of debt		2,148	4,181
Loss on repurchase of warrants	20,246	4,243
Write-off of deferred financing costs	1,926		1,845
Stock-based compensation expense	6,158	5,773	11,560
Changes in:
Trade receivables	(9,845)	6,594	3,561
Interest receivable	(4,978)	(3,142)	(690)
Accounts payable and accrued liabilities	(16,719)	6,038	(59,395)
Other assets and liabilities	552	3,077	8,525
Net cash flows provided by operating activities	234,362	247,004	137,699
Cash Flows from Investing Activities:
Purchases of property and equipment	(79,815)	(58,377)	(36,959)
Purchase of AC Hotel		(21,206)
Proceeds from sale of Peterson LOI	10,000	9,350
(Increase) decrease in restricted cash and cash equivalents	(4,945)	2,759	(13,959)
Other investing activities	123	8,012	2,177
Net cash flows used in investing activities	(74,637)	(59,462)	(48,741)
Cash Flows from Financing Activities:
Net borrowings (repayments) under credit facility	(280,100)	77,000	(35,500)
Net borrowings (repayments) under term loan B	(4,000)	398,000
Issuance of senior notes	400,000		350,000
Early redemption of senior notes			(152,180)
Repurchase and conversion of convertible notes		(358,710)	(99,222)
Repurchase of common stock warrants	(154,681)	(177,423)
Deferred financing costs paid	(11,155)	(8,428)	(15,738)
Repurchase of Company stock for retirement			(100,028)
Payment of dividend	(131,305)	(109,414)	(76,424)
Proceeds from exercise of stock options	1,777	6,862	5,223
Other financing activities	(378)	(600)	(680)
Net cash flows used in financing activities	(179,842)	(172,713)	(124,549)
Net change in cash and cash equivalents	(20,117)	14,829	(35,591)
Cash and cash equivalents - unrestricted, beginning of period	76,408	61,579	97,170
Cash and cash equivalents - unrestricted, end of period	$ 56,291	$ 76,408	$ 61,579